Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.8.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LV.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
LV.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.54.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.54.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.7ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.30.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.30.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.1.1.4ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.1.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MN.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
MN.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.63ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LE.1.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
LE.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LH.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
LH.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
HW.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HW.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
JN.1.55.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.55.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.18.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.18.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.4.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XDK.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.4.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.3.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.11ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.2.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LS.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
LS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1 (Omicron)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.1.1 (Omicron)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.14ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.5.2.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4 (Omicron)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BA.4 (Omicron)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BA.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BA.5.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FL.5.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FL.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HD.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HD.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HQ.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FD.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used